FilingSEC EDGAR6-K
Innate Pharma closes Sobi partnership and completes €30 million capital increase
· SEC accepted
StageClinical and Business Expansion
Filing content
Innate Pharma received a $75 million upfront payment from its Sobi partnership and completed a €30 million capital increase, extending its cash runway through Q1 2028.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…